Aspen Aerogels, Inc. (NYSE:ASPN) Receives $6.67 Consensus PT from Brokerages

Aspen Aerogels, Inc. (NYSE:ASPN) has been given a consensus recommendation of “Hold” by the seven ratings firms that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $4.50.

Several research firms have recently commented on ASPN. TD Cowen reduced their target price on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating for the company in a research note on Thursday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, December 29th. Canaccord Genuity Group decreased their price objective on shares of Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating for the company in a report on Friday, November 7th. Barclays dropped their target price on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a research report on Friday, November 7th. Finally, Zacks Research upgraded shares of Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 15th.

Aspen Aerogels Stock Up 22.2%

Shares of Aspen Aerogels stock opened at $3.14 on Tuesday. Aspen Aerogels has a 1-year low of $2.30 and a 1-year high of $9.78. The company has a market capitalization of $259.52 million, a PE ratio of -0.66 and a beta of 2.99. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33. The business has a 50-day moving average of $3.32 and a 200-day moving average of $5.07.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings results on Wednesday, February 25th. The construction company reported ($0.34) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.07). Aspen Aerogels had a negative net margin of 143.69% and a negative return on equity of 13.07%. The business had revenue of $41.34 million during the quarter, compared to analysts’ expectations of $44.25 million. During the same period in the prior year, the company posted $0.14 EPS. The company’s revenue for the quarter was down 66.4% on a year-over-year basis. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. As a group, equities analysts forecast that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Royal Bank of Canada increased its holdings in shares of Aspen Aerogels by 84.7% in the 1st quarter. Royal Bank of Canada now owns 56,419 shares of the construction company’s stock valued at $360,000 after acquiring an additional 25,880 shares during the last quarter. AQR Capital Management LLC acquired a new position in Aspen Aerogels in the first quarter worth $960,000. Integrated Wealth Concepts LLC bought a new stake in Aspen Aerogels during the first quarter valued at $84,000. Goldman Sachs Group Inc. raised its holdings in shares of Aspen Aerogels by 89.7% during the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after purchasing an additional 602,586 shares during the period. Finally, Caxton Associates LLP bought a new position in shares of Aspen Aerogels in the 1st quarter worth about $307,000. Institutional investors own 97.64% of the company’s stock.

Key Headlines Impacting Aspen Aerogels

Here are the key news stories impacting Aspen Aerogels this week:

• Positive Sentiment: Company cited a strong liquidity position and strategic actions — $158.6M year-end cash, an expected ~$37.6M GM commercial settlement in Q1 and initiation of a strategic review (Piper Sandler engaged) to optimize capital structure and options, which supports near-term solvency and optionality. Read More.
• Positive Sentiment: Commercial momentum in Energy Industrial: company highlighted a North Sea subsea pipeline award, ongoing European OEM (EV) program progress and set a 20% Energy Industrial segment growth target for 2026 — signals that project pipeline and non-EV end markets could help revenue recovery. Read More.
• Positive Sentiment: Some analysts remain constructive: TD Cowen kept a “buy” rating (PT lowered to $6 but still implies large upside vs. current levels), indicating at least one major shop sees recovery potential if strategy execution improves. Read More.
• Neutral Sentiment: Roth MKM lowered its price target from $6 to $3 while retaining a “buy” rating — mixed signal: valuation expectations trimmed but the buy stance suggests upside if turnaround actions succeed. Read More.
• Negative Sentiment: Sharp earnings/revenue deterioration — Q4 revenue plunged to $41.3M (vs. $123.1M a year earlier) and GAAP net loss of $72.9M (adjusted loss still negative). The company recorded a $291.2M impairment for the year, driving a large full-year net loss. Those results materially weaken near-term fundamentals. Read More.
• Negative Sentiment: Guidance disappointed: Q1 2026 EPS guide of -$0.28 to -$0.24 and revenue guidance $35M–$40M both miss consensus (revenue vs. ~$44M), signaling continued near-term weakness and keeping pressure on margins and cash flow. Read More.
• Negative Sentiment: Investor legal risk: a shareholder law firm (Johnson Fistel) announced an investigation into potential claims tied to Aspen’s executives and investor losses — adds litigation/PR risk and can amplify selling pressure. Read More.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.